Loading...
IMCD logo

IMCD N.V.ENXTAM:IMCD Stock Report

Market Cap €5.9b
Share Price
€100.15
€107.68
7.0% undervalued intrinsic discount
1Y-15.7%
7D3.9%
Portfolio Value
View

IMCD N.V.

ENXTAM:IMCD Stock Report

Market Cap: €5.9b

IMCD (IMCD) Stock Overview

Distributes, markets, and sells specialty chemicals and ingredients in the Netherlands, rest of Europe, the Middle East, Africa, North America, South America, and the Asia-Pacific. More details

IMCD fundamental analysis
Snowflake Score
Valuation2/6
Future Growth1/6
Past Performance2/6
Financial Health3/6
Dividends4/6

IMCD Community Fair Values

Create Narrative

See what 23 others think this stock is worth. Follow their fair value or set your own to get alerts.

Community Contributor
CA$5.25FV 4.8% undervalued intrinsic discount
30989.3%Revenue growth p.a.
1.1k
4
0
20
11d ago

IMCD N.V. Competitors

Price History & Performance

Summary of share price highs, lows and changes for IMCD
Historical stock prices
Current Share Price€100.15
52 Week High€126.55
52 Week Low€68.14
Beta0.95
1 Month Change12.43%
3 Month Change27.13%
1 Year Change-15.73%
3 Year Change-27.32%
5 Year Change-18.51%
Change since IPO347.70%

Recent News & Updates

Recent updates

IMCD: Margin Execution And Revenue Mix Should Support Future Re Rating

Analyst price targets for IMCD have edged lower, with recent cuts of €5 to €7 from several banks and a reset range between about €103 and €122. Analysts are factoring in a slightly higher discount rate, a lower assumed future P/E multiple and updated expectations for revenue growth and margins.

IMCD: Dividend Cut And Lowered Expectations Will Pressure Future Returns

IMCD's updated analyst price target has edged lower by a few euros, with recent revisions between about €103 and €122. These reflect analysts' mixed adjustments to growth, margin and P/E assumptions.

IMCD: Lower Dividend And Reset Expectations Will Set Up Future Upside

The Analyst Price Target for IMCD has shifted lower to €107.68 from €126.46, reflecting analysts' updated views on slightly softer revenue growth, thinner profit margins and a lower future P/E multiple, supported by a series of recent price target cuts and one upward revision across major banks. Analyst Commentary Recent research shows a mix of optimism and caution around IMCD, with several banks trimming price targets and one raising them, which helps explain why the average target has reset closer to current expectations.

IMCD: Sector Caution And Dividend Reset Will Shape Future Expectations

Analysts have trimmed the IMCD price target, with recent revisions clustering around €100 to €122. This reflects updated views on sector conditions and modest adjustments to revenue growth, discount rate and profit margin assumptions.

IMCD: Sector Caution And New Partnership Will Shape Future Expectations

The analyst fair value estimate for IMCD has been adjusted from €82.00 to €75.00. Analysts cite recent price target changes across major banks, along with more cautious assumptions on discount rates, revenue growth, and margins, as the key drivers of the updated view.

IMCD: Distribution Expansion And CFO Transition Will Support Future Re Rating

Analysts have trimmed their price targets for IMCD by about €14, citing slightly higher discount rate assumptions, revised profit margin expectations, and recent cautious sector views. These developments are reflected in lower price targets and a downgrade to Equal Weight.

IMCD: Cautious Sector Outlook And New Partnership Will Shape Expectations

Analysts have reduced their fair value estimate for IMCD from €107.00 to €82.00. This reflects a lower future P/E assumption and a slightly reduced profit margin outlook, in line with recent Street research that has turned more cautious on chemical distribution and related services.

IMCD: Distribution Deal And CFO Transition Will Support Sector Re Rating

Analysts have lowered their price target on IMCD to about €170.50 from roughly €176.73, citing a reset in sector expectations following cautious views on chemical distribution and a shift in preferred names within European business services. Analyst Commentary Recent research has shifted IMCD to a more neutral stance within European business services, with the rating moved to Equal Weight and the price target set at €100 from €139.

Is There An Opportunity With IMCD N.V.'s (AMS:IMCD) 50% Undervaluation?

Jan 20
Is There An Opportunity With IMCD N.V.'s (AMS:IMCD) 50% Undervaluation?

IMCD: Share Pullback Will Set Up Upside Following New Outperform Coverage

Analysts have trimmed their fair value estimate for IMCD from €127.18 to €126.46, reflecting slightly softer assumptions for revenue growth and profit margin, even as some recent research, including new Outperform coverage, points to potential upside after the recent share pullback. Analyst Commentary Bullish Takeaways Bullish analysts view the recent share pullback as creating a more appealing entry point relative to their updated fair value and the new $72.50 price target.

IMCD Will Likely Gain From New Distribution Deal And Leadership Transition

Analysts have trimmed their fair value estimate for IMCD to approximately €177 from about €182, reflecting slightly higher discount rate assumptions, more moderate revenue growth expectations, and a marginally lower future P/E, partially offset by a firmer margin outlook and recent supportive rating actions despite reduced price targets. Analyst Commentary Bullish analysts continue to frame IMCD as a quality compounder within the specialty chemicals distribution space, highlighting the recent share pullback as an opportunity rather than a sign of structural deterioration.

IMCD: Share Pullback Will Offer Opportunity As New Outperform Ratings Emerge

The analyst price target for IMCD has been trimmed modestly from EUR 131.25 to about EUR 127.18, as analysts factor in slightly slower growth and margin assumptions, even as they highlight recent upgrades and new Outperform initiations as support for a still constructive outlook. Analyst Commentary Recent research updates point to a broadly constructive stance on IMCD, with most commentary emphasizing resilient fundamentals and an attractive entry point following the share price pullback, even as some valuation and macro risks are flagged.

Some Shareholders Feeling Restless Over IMCD N.V.'s (AMS:IMCD) P/E Ratio

Nov 27
Some Shareholders Feeling Restless Over IMCD N.V.'s (AMS:IMCD) P/E Ratio

IMCD: Share Pullback Will Offer Opportunity As Revenue Momentum Builds

IMCD's analyst price target has been revised down from €138.04 to €131.25. Analysts cite moderate adjustments in fair value and market outlook, despite recent supportive coverage and an improved revenue growth forecast.

Does IMCD (AMS:IMCD) Have A Healthy Balance Sheet?

Nov 12
Does IMCD (AMS:IMCD) Have A Healthy Balance Sheet?

IMCD: Share Price Pullback Will Offer Attractive Entry As Ratings Improve

The analyst fair value estimate for IMCD has been reduced from EUR 142.43 to EUR 138.04. Analysts cite more cautious assumptions on long-term revenue growth and profit margin forecasts following recent price target adjustments in Street research.

At €93.80, Is IMCD N.V. (AMS:IMCD) Worth Looking At Closely?

Oct 28
At €93.80, Is IMCD N.V. (AMS:IMCD) Worth Looking At Closely?

Analyst Commentary Highlights Mixed Views on IMCD Amid Minor Valuation Adjustments

Analysts have slightly lowered their fair value estimate for IMCD by less than 1 percent to approximately €142.43. This reflects minor adjustments in growth expectations and recent Street research supporting a cautiously positive outlook, despite recent target downgrades.

Returns On Capital At IMCD (AMS:IMCD) Have Hit The Brakes

Oct 12
Returns On Capital At IMCD (AMS:IMCD) Have Hit The Brakes

Digitalization And M&A Will Expand Pharma And Consumer Markets

IMCD's analyst price target has decreased moderately, from €145.43 to €143.00, as analysts factor in slightly lower expected growth and a reduced profit margin outlook in recent industry assessments. Analyst Commentary Analyst opinions on IMCD remain divided as recent price target changes and rating updates reflect a mix of optimism regarding potential growth and caution due to evolving sector dynamics.

Digitalization And M&A Will Expand Pharma And Consumer Markets

Analysts cite attractive valuation, improved capital allocation, and stabilizing end markets as supportive, but near-term earnings uncertainty and ongoing macroeconomic headwinds have kept IMCD’s consensus price target unchanged at €145.43. Analyst Commentary Valuation now seen as attractive, with shares offering growth at a reasonable price.

An Intrinsic Calculation For IMCD N.V. (AMS:IMCD) Suggests It's 44% Undervalued

Sep 01
An Intrinsic Calculation For IMCD N.V. (AMS:IMCD) Suggests It's 44% Undervalued

We Think IMCD (AMS:IMCD) Can Stay On Top Of Its Debt

Aug 04
We Think IMCD (AMS:IMCD) Can Stay On Top Of Its Debt

There's Reason For Concern Over IMCD N.V.'s (AMS:IMCD) Price

Jul 21
There's Reason For Concern Over IMCD N.V.'s (AMS:IMCD) Price

Return Trends At IMCD (AMS:IMCD) Aren't Appealing

Jul 04
Return Trends At IMCD (AMS:IMCD) Aren't Appealing

Are Investors Undervaluing IMCD N.V. (AMS:IMCD) By 28%?

May 09
Are Investors Undervaluing IMCD N.V. (AMS:IMCD) By 28%?
User avatar

The Company'S Digital Upgrades And M&A Strategy Ignite Growth Potential Amid Challenges

Continued organic growth through commercial excellence and digital upgrades could boost future revenue and earnings.

Shareholder Returns

IMCDNL Trade DistributorsNL Market
7D3.9%-0.4%-1.5%
1Y-15.7%7.5%27.5%

Return vs Industry: IMCD underperformed the Dutch Trade Distributors industry which returned 8.7% over the past year.

Return vs Market: IMCD underperformed the Dutch Market which returned 31.5% over the past year.

Price Volatility

Is IMCD's price volatile compared to industry and market?
IMCD volatility
IMCD Average Weekly Movement7.1%
Trade Distributors Industry Average Movement5.4%
Market Average Movement4.7%
10% most volatile stocks in NL Market8.2%
10% least volatile stocks in NL Market2.9%

Stable Share Price: IMCD's share price has been volatile over the past 3 months compared to the Dutch market.

Volatility Over Time: IMCD's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Dutch stocks.

About the Company

FoundedEmployeesCEOWebsite
19955,246Marcus Jordanwww.imcdgroup.com

IMCD N.V. distributes, markets, and sells specialty chemicals and ingredients in the Netherlands, rest of Europe, the Middle East, Africa, North America, South America, and the Asia-Pacific. The company provides adhesives, core materials, filler reinforcements, flame retardants, masterbatch, modifiers, operating materials, pigments, plasticizers, processing aids, PUR raw materials, rubber elastomers, solvents, stabilizers, thermoplastic elastomers, thermoplastics, thermoplastics, and other additives. It offers actives, UV sunscreens, rheology modifiers, thickeners, surfactants, emulsifiers, emollients, film formers, humectants, waxes, conditioners, hair styling polymers, solvent, solubilizers, pigments, pearls, powders and colorants, opacifiers, pearlizers, preservatives, antioxidants, fragrances, and essential oils.

IMCD N.V. Fundamentals Summary

How do IMCD's earnings and revenue compare to its market cap?
IMCD fundamental statistics
Market cap€5.91b
Earnings (TTM)€217.58m
Revenue (TTM)€4.81b
27.2x
P/E Ratio
1.2x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IMCD income statement (TTM)
Revenue€4.81b
Cost of Revenue€3.59b
Gross Profit€1.22b
Other Expenses€1.00b
Earnings€217.58m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

Jul 29, 2026

Earnings per share (EPS)3.69
Gross Margin25.38%
Net Profit Margin4.53%
Debt/Equity Ratio82.6%

How did IMCD perform over the long term?

See historical performance and comparison

Dividends

1.8%
Current Dividend Yield
49%
Payout Ratio

Does IMCD pay a reliable dividends?

See IMCD dividend history and benchmarks
When do you need to buy IMCD by to receive an upcoming dividend?
IMCD dividend dates
Ex Dividend DateMay 05 2026
Dividend Pay DateMay 08 2026
Days until Ex dividend2 days
Days until Dividend pay date5 days

Does IMCD pay a reliable dividends?

See IMCD dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/02 14:16
End of Day Share Price 2026/04/30 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

IMCD N.V. is covered by 23 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gaurav JainBarclays
James StewartBarclays
Anil ShenoyBarclays